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The quantity and the electrophoretic characteristics of desmin were analyzed in a familial skeletal muscle disorder, charac- 
terized by the intra-sarcoplasmic accumulation of an electron-dense granule-filamentous material facing the Z-lines and 
reacting strongly with polyclonal anti-desmin antibodies. The analysis was performed on biopsies from the deltoid mus- 
cles of 4 patients. members of 2 families. In the 4 biopsies, an increase in the relative amount of desmin compared to 
that of actin or insoluble proteins (3 fold) and in the number of isovariants (6 instead of 3) was observed. The isovariants 
of desmin were similar to those described in Purkinje fibres of the heart as a phosphorylated form of the protein [(1987) 
Eur. J. Cell Biol. 44, 68-781. Therefore, post-translational events could affect both the polymerization and the amount 
of desmin filaments in this autosomal dominant familial myopathy. 
Familial cardiomyopathy; Desmin immunoquantitation; Desmin isovariant; (Skeletal muscle) 
1. INTRODUCTION 
A familial muscular disorder characterized by an 
intra-sarcoplasmic accumulation of an electron- 
dense granulo-filamentous material was described 
in 1978 by Fardeau et al. [l]. Recently these 
authors revealed by immunohistochemical la- 
belling that this material reacts specifically with 
anti-desmin antibodies [2]. In adult skeletal muscle 
desmin is the constitutive protein of the inter- 
mediate filaments (IFS) that link individual myo- 
fibrils laterally at their Z disks and to the sarco- 
lemma [3]. An accumulation of IFS has also been 
described in other muscular diseases by electron 
microscopy [4--61, but it was not clear if it was the 
result of a relative decrease in the amount of 
myofibrillar proteins and/or in an increase in IFS 
with altered capacities of polymerization. 
The regulatory mechanisms that govern IF 
assembly-disassembly are not known. It was found 
recently that vimentin [7] and desmin [8] when 
phosphorylated in vitro by protein kinase A lose 
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their ability to form normal IFS. In vivo phospho- 
rylation of desmin results in an increased number 
of isovariants 191. 
Therefore in order to better characterize the 
familial disorder described by Fardeau et al. [l] we 
have used immunological methods to analyse both 
the electrophoretic characteristics and the quantity 
of desmin in the skeletal muscle biopsies presenting 
an ultrastructural accumulation of electron-dense 
granulo-filamentous material. Since the resistance 
of IFS to extraction has been well documented [lo] 
a one step partial purification of desmin was per- 
formed prior to the quantitative and qualitative 
analysis. A simple and sensitive method for 
evaluating the amount of desmin as a function of 
the protein and/or actin content in the extract was 
adapted using a dot-blot immunolabelling tech- 
nique. Actin was chosen as an internal marker 
since the protein is known to be strongly associated 
with desmin throughout the purification processes 
[ 1 l] and since we observed that its relative amount 
in the protein extracts did not vary significantly 
among biopsies from controls and patients. The 
present experiments show that in the 4 patients’ 
biopsies analysed, there is an increase in both the 
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amount (2-3.8-fold) and the number of iso- 
variants (up to 6) of desmin. 
2. MATERIALS AND METHODS 
Biopsies were obtained from deltoid muscles of 4 adult pa- 
tients, 3 of them belonging to the same family (fig.1). The 
diagnosis was based on clinical symptoms and characteristic 
morphological changes [I]. Clinically it is characterised by a 
hypertrophic cardiomyopathy with a diffuse, symmetrical, non- 
selective involvement of skeletal muscles predominantly in 
distal and velopharyngeal muscles. Muscle biopsies, from pa- 
tients displaying no clinically definite muscle disease and which 
were considered to be morphologically normal, were used as 
controls. 
Biopsy material, previously frozen in liquid nitrogen and 
stored at - 8O”C, was homogenized at 4°C in 20 vols of 5 mM 
Hepes (pH 7.5), 25 mM sucrose, 2 mM phenylmethylsulfonyl 
fluoride (PMSF), 1 mM dithiothreitol (DTT) with protease in- 
hibitor (1 /g/ml leupeptine, 0.5 mM benzamidine, 5 pg/ml of 
M-tosyl phenylalanine chloromethylketone (TPCK), using a 
polytron PT lo-35 homogenizer (1 time 5 s, plot 2 and 2 times 
5 s, plot 3). 0.5% Triton X-100 was added and the samples were 
gently mixed for 15 min at 4°C and centrifuged (15 min at 
10000 rpm (rotor Sorvall SS-34). The pellet was solubilized in 
50 mM Tris-HCl (pH 7.7), 5 mM MgCl2, 0.01% DNase, 
0.005% RNase, 0.1 mM PMSF, 8 M urea, 0.5% SDS, 1% 
2-mercaptoethanol, and protease inhibitors in the same amount 
as above. Aliquots were stored frozen at - 20°C. Protein con- 
tent was determined by Bradford’s procedure [12]. 
The anti-actin antibodies were obtained from Miles Labora- 
tory. Immunoquantitation and immunoblotting of desmin were 
performed using polyclonal immune serum raised in rabbit im- 
munized with electrophoretically eluted chicken gizzard desmin 
extracted according to Geisler and Weber [12]. The antidesmin 
antiserum was characterized by the Ouchterlony test, im- 
munofluorescence labelling of cardiac cells (not shown) and im- 
munotransfer (see fig.2). 
Mono- and two-dimensional gel electrophoresis (mini- 
apparatus, Biorad) were performed with slightly modified con- 
ditions from Laemmli [13] and O’Farrell [14], adapted for 
cvtnckeletal nmtdnn: rlertrofncurin~ PPI~ Ih.6 cm\ mntaininv -, ----------- r- -------. ______ _ _ _ _______ ____ \-.- ----I ---------e--m 
1.6% ampholine pH 4-6.5, and 0.4% ampholine 2D pH 3-10 
(Pharmacia) were run for 1250 V. h. Equilibration was per- 
formed just prior to the run of the second dimension. Equal 
amounts of protein (30 pg) were applied on each gel. Proteins 
electrophoretically transferred to nitrocellulose sheets accord- 
ing to the method of Towbin et al. [15] were either stained with 
ink [16] or immunolabelled. 
lmmunoquantitation of desmin was an adaptation to dot- 
blot (SRC 96 apparatus from Schleicher and Schull) of 
Burnette’s method [17]. Briefly, aliquots (80 rl) of increasing 
amnunrs nf nrnteins from insoluble extra&q WFTP hlotted onto - . .._ - ..- -_ r- ------- ______ . .._ - .--._ _.._. -___ _._ - .____ - -.__ - 
nitrocellulose sheets previously soaked in 25 mM Tris, 192 mM 
glycine and 20% methanol. After preincubation with 5% 
bovine serum albumin (BSA) and washing in 10 mM Tris-HCl 
(pH 8.3), 0.9% NaCl, 0.05% NP-40, proteins were probed for 
reactivity with desmin anti-serum (l/250) or actin antibodies 
(l/ 100). The amount of either desmin or actin on each dot was 




cl 70t45 n t 62 .t 70 
v +l 
n t49 , ( , ,T,~“‘i+6~ 
ym& q nooooooo 
?clO q 00m00 
Family S. 
r-k& 
q k4 .T ‘;P 
M.,m q 0 0 
Fig.1. Family trees of the patients (MI-M4) whose biopsies 
presented ultrastructural alterations and accumulation of IFS. 
protein A (2.5 x 10’ cpm/ml for 60 min). After washing the ex- 
tent of “‘I-protein A binding was visualized by exposure of the 
nitrocellulose sheet to an X-ray film, then the dots were excised 
and the amount of radioactivity determined. The latter was 
plotted as a function of the protein loaded on each dot. 
3. RESULTS AND DISCUSSION 
Fig.2 shows that after one step partial purifica- 
tion desmin and actin extracted from muscle biop- 
sies were concentrated in the pellet rich in 
myofibrillar proteins. The desmin antiserum and 
anti-actin antibodies reacted only against desmin 
and actin, respectively. 
Electrophoretic characteristics of desmin were 
analysed by 2D gel electrophoresis (fig.3). Both 
ink-staining and immunolabelling revealed that in 
all the controls desmin had the classical pattern of 
2-3 isovariants, the more basic with the isoelec- 
trofocusing characteristics of a-actin being the 
more important. In biopsies from patients desmin 
appeared to be composed of up to 6 isovariants of 
similar size, 3 of which were similar to those of the 
controls and the other three being more acidic. In 
fact an identical electrophoretic pattern of desmin 
has been observed in normal cardiac Purkinje 
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Fig.2. Gel electrophoresis of normal human muscle extracts. 
Soluble (lane a) and pellet extracts (lanes b-d) were stained with 
ink (lane a,b), with desmin antiserum (lane c) or with anti-actin 
antibodies (lane d). Actin and desmin are respectively marked 
as A and D. 
fibres [18] where it was described as a highly 
phosphorylated form of the protein [9]. 
Furthermore it appeared from the ink staining 
of the nitrocellulose sheet that the intensity of 
_r..:_:__ _c rL_ A....-:- ..-_*_ ._._^ _I_--1.. 1_ _____. J b~ilmmg VI LII~ U~~IIIIII bpulb was clearly mcreaseu 
in patient’s biopsies whilst that of actin spots did 
not vary among biopsies from controls and pa- 
tients. Therefore, this apparent increase in the 
amount of desmin in the biopsies was further 
evaluated by immunoquantitation. Fig.4 is a 
typical curve of the immunoquantitation of desmin 
following dot-blot immunolabelling with desmin 
antiserum and “‘I-Protein A of increasing 
. ..-^.._*.. -I ---r-:- ___*-_ _I_ TL _ illll”UIILS “I pruLelll tX11ac1s. 1ne amount of 
desmin and actin (not shown) in each muscle ex- 
tract were evaluated in the linear portion of the 
curves as cpm of bound ‘251-Protein A per pg of 
loaded protein. The data summarized in table 1, 
show that in biopsies from 3 of the 4 patients (Mz, 
Mj, M4) the amount of desmin was greater than in 
controls whilst that of actin remained constant. As 
a consequence the desmin/actin ratio (D/A) was 
markedly increased in these biopsies. Interestingly 
in the Mr biopsy, the amount of desmin appeared 
to be similar to that of control muscles and only 
the actin quantitation enables us to reveal an in- 
crease in the D/A ratio as in the other biopsies. 
In conclusion we have shown that the accumula- 
tion of intra-sarcoplasmic electron-dense granulo 
filaments of desmin, previously reported to char- 
acterize a familial muscle disorder [l] is accom- 
panied by a large increase (up to 3.8 fold) in the 
amount of a desmin that has the typical electro- 
phoretic pattern of the phosphorylated form of the 
protein [9]. 
The question that arises is whether any relation- 
ship exists between the alterations in the distribu- 
tion and polymerisation state of IFS and the 
increase in the concentration and phosphorylation 
state of their constitutive protein. In vitro both 
kinase A and kinase C are able to phosphorylate 
the IF protein desmin [8] and vimentin [9] but only 
kinase A has been shown to induce a transition 
towards the depolymerized state of the IFS [7,8]. 
IFS with highly phosphorylated forms of desmin 
appeared either as filaments normally localised at 
the level of Z discs in cardiac Purkinje fibres [9] or 
as a granulo-filamentous material in pathological 
skeletal muscle ([l] and this paper). This suggests 
that in vivo the phosphorylation sites of desmin 
may be differently implicated in impaired filament 
formations. In vivo the modulation of the IF struc- 
ture and organisation was shown to depend at least 
partially on a kinase A dependent single site- 
. C. 
speciric phosphoryiation ]i9j. 
According to studies on neurofilaments, phos- 
phorylation might be a factor implicated in 
stabilizing compacted forms of filaments [20]. It 
could be postulated that similarly phosphorylation 
of desmin increases IF stability and thus favors the 
relative accumulation of the protein observed in 
both cardiac Purkinje fibres [18] and in the 
pathological skeletal muscle (this paper). 
Numerous uitrastructurai studies have described 
abnormalities in the intermediate filaments distri- 
bution in different muscular diseases [4-61 and re- 
cent in vitro analyses have focused on the role of 
phosphorylation of vimentin and desmin on the 
IFS state of polymerization [7,8]. This study is the 
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Fig.3. Increase in the number of isovariants of desmin in the biopsies from members of the two families showing intra-sarcoplasmic 
accumulation of IFS. Equal amounts of protein of the pellet extracts were submitted to %D-polyacrylamide gel electrophoresis and 
transferred onto a nitrocellulose sheet stained either with ink (a) or antidesmin labelled with “‘I-protein A (b). Ml and Mz* are two 
biopsies taken at different time intervals from the same patient. 
0 2 4 6 
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Fig.4. Typical curve of the immunoquantitation of desmin in a 
pellet extract from control (CZ) and patient’s biopsies (M,). The 
amount of “?-protein A bound on each dot was expressed as 
a function of the amount of protein applied. The relative 
amount of desmin in each biopsy extract was evaluated in the 
linear portion of the curve. 
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Table 1 
Storage of desmin in myopathy 
Desmin (D) Actin (A) 
(cpmiflg (cpm/pg 
insol. prot.) insol. prot.) 
D/A 
Control 
(n = 7) 247 f 31* 383 + 28* 0.66 k 0.08* 
Myopathy 
Family L. 
Ml 280 (x 1.13) 199 (x 0.52) 1.41 (x 2.1) 
M2 1076 (x 4.36) 429 (x 1.12) 2.51 (X 3.8) 
M3 800 (x 3.24) 450 (x 1.17) 1.78 (x 2.7) 
Family S. 
M4 916 (x 3.71) 401 (x 1.05) 2.28 (x 3.4) 
Data were calculated according to the immunoquantitation 
method described in section 2. n, number of samples. 
*, mean * SE 
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first demonstration of an in vivo alteration of 
desmin characteristics which are associated with 
changes in the IF organization. These results are in 
favor of an impairment at the level of the specific 
enzymatic control of phosphorylation-dephospho- 
rylation events that may be involved in the 
physiological modulation of intermediate filament 
integrity and structure. The nature of the gene 
responsible for this desmin disorder and the 
relative importance of this impairment in the 
development of the clinical syndrome observed in 
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